title: Looking to a future of improved diabetes management: interview with Professor Steve Bain.
abstract: Steve Bain talks to Francesca Lake, Managing Editor:Steve is currently a Professor at Swansea University Medical School (Wales), Assistant Medical Director for Research & Development for ABM University Health Board and Clinical Lead for the Diabetes Research Unit, Wales. His clinical training included research into the genetics of Type 1 diabetes, with his current clinical interests surrounding exercise in Type 1 diabetes, new therapies and the provision of diabetes services. His background has led him to be Principal Investigator for several multicenter trials, and to be involved in various ethical committees concerning genetics. He led the UK Human Genetics Commission's report on DNA testing in 2009, and in 2007 was invited to sit on the National DNA Database Ethics Group, established by the Secretary of State for the Home Department. Steve is also a member of the Wales Diabetes & Endocrine Society executive committee and chairs the Specialist Training Committee for Diabetes & Endocrinology for Wales. He also chairs the Board that oversees the Institute of Life Science Joint Clinical Research Facility, the premier clinical research institute in Wales.
authors.affiliation: Institute of Life Science, Swansea University & Clinical Director, Diabetes Research Unit Cymru, Swansea, Wales, SA2 8PP.
authors.forename: Steve
authors.initials: S
authors.lastname: Bain
keywords: Type 2 diabetes; cardiovascular events; diabetes; semaglutide